Fig. 8

Potential therapeutic drugs for ccRCC based on SRlncRNA signature. A Different drug sensitivities of samples in low- and high-risk groups. The lower the IC50 value, the higher the sensitivity of the drug. B Intersection of the candidate drugs in L1000FWD, CMap and DGIdb database. C Structures of the candidate drugs in the intersection